{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T10:25:32Z","timestamp":1775039132054,"version":"3.50.1"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      5-fluorouracil-based regimen FOLFOX (5-fluorouracil, folinic acid, oxaliplatin) is the first-line chemotherapeutic for metastatic colorectal cancer patients. On the other hand, the medicinal herb\n                      <jats:italic>Patrinia villosa<\/jats:italic>\n                      (Thunb.) Dufr. [Caprifoliaceae] is commonly prescribed by Chinese medicine practitioners to colorectal cancer patients in recent years. Thus, the possibility of concurrent use of\n                      <jats:italic>P. villosa<\/jats:italic>\n                      with FOLFOX occurs. The present study aimed to investigate whether\n                      <jats:italic>P. villosa<\/jats:italic>\n                      water extract would interfere with the metabolism and anti-tumor efficacy of chemotherapy regimen FOLFOX in preclinical colon cancer models.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Human HCT-116 xenograft-bearing and murine Colon-26 orthotopic tumor-bearing mouse models were established and received FOLFOX and\/or PV water extract treatments for 3\u00a0weeks. FOLFOX was administered intravenously once a week and PV water extract was administered daily by oral gavage except on the FOLFOX administration day. The levels of metabolising enzymes dihydropyrimidine dehydrogenase (for 5-fluorouracil), serine hydroxymethyltransferase (for folinic acid), as well as molecules, cysteine, methionine and reduced glutathione, involved in oxaliplatin biotransformation, were determined in plasma of xenograft-bearing mice receiving FOLFOX and\/or PV water extract treatment. The tumor progression, metastasis and tumor microenvironment in mice were also assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The PV water extract treatment did not affect the plasma levels of metabolising enzymes of 5-fluorouracil and folinic acid, nor the plasma levels of cysteine, methionine and reduced glutathione in HCT-116 xenograft-bearing mice. On the other hand, the combined treatment of FOLFOX and PV water extract inhibited both HCT-116 and Colon-26 tumor growth, with HCT-116 tumor weight of FOLFOX plus PV water extract group being the lowest among all treated groups. PV water extract treatment could further potentiate the anti-angiogenesis, apoptosis and immunomodulatory effect of FOLFOX in colon tumors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This is the first report to demonstrate that no observable interference induced by PV water extract on the plasma levels of selected metabolism enzymes and precursor molecules of FOLFOX component drugs in colon tumor-bearing mice. The combined use of FOLFOX plus PV water extract resulted in better anti-tumor efficacy in colon cancer mouse models than single treatment alone. The beneficial potentials of combined use of FOLFOX and PV water extract has been scientifically verified, which supports the clinical use in colon cancer management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1756234","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T08:17:41Z","timestamp":1775031461000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Can Patrinia villosa water extract be taken during FOLFOX treatment in colon cancer? \u2013 evidences from a proof-of-concept preclinical study"],"prefix":"10.3389","volume":"17","author":[{"given":"Grace Gar-Lee","family":"Yue","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong","place":["Hong Kong, Hong Kong SAR, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kit-Man","family":"Lau","sequence":"additional","affiliation":[{"name":"Institute of Chinese Medicine, The Chinese University of Hong Kong","place":["Hong Kong, Hong Kong SAR, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dandan","family":"Hu","sequence":"additional","affiliation":[{"name":"Institute of Chinese Medicine, The Chinese University of Hong Kong","place":["Hong Kong, Hong Kong SAR, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ka-Ki","family":"Yuen","sequence":"additional","affiliation":[{"name":"Institute of Chinese Medicine, The Chinese University of Hong Kong","place":["Hong Kong, Hong Kong SAR, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia Kin-Ming","family":"Lee","sequence":"additional","affiliation":[{"name":"Institute of Chinese Medicine, The Chinese University of Hong Kong","place":["Hong Kong, Hong Kong SAR, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si","family":"Gao","sequence":"additional","affiliation":[{"name":"Institute of Chinese Medicine, The Chinese University of Hong Kong","place":["Hong Kong, Hong Kong SAR, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaotong","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong","place":["Hong Kong, Hong Kong SAR, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon Siu-Man","family":"Ng","sequence":"additional","affiliation":[{"name":"Department of Surgery, The Chinese University of Hong Kong","place":["Hong Kong, Hong Kong SAR, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhong","family":"Zuo","sequence":"additional","affiliation":[{"name":"School of Pharmacy, The Chinese University of Hong Kong","place":["Hong Kong, Hong Kong SAR, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kam Wa","family":"Chan","sequence":"additional","affiliation":[{"name":"School of Chinese Medicine, Hong Kong Baptist University","place":["Hong Kong, Hong Kong SAR, China"]},{"name":"Vincent V.C. Woo Chinese Medicine Clinical Research Institute, School of Chinese Medicine, Hong Kong Baptist University","place":["Hong Kong, Hong Kong SAR, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara Bik-San","family":"Lau","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong","place":["Hong Kong, Hong Kong SAR, China"]},{"name":"Institute of Chinese Medicine, The Chinese University of Hong Kong","place":["Hong Kong, Hong Kong SAR, China"]},{"name":"School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong","place":["Hong Kong, Hong Kong SAR, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.1200\/JCO.2008.20.6771","article-title":"Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial","volume":"27","author":"Andre","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"B3","first-page":"39","article-title":"Clinical and pharmacokinetics study of oxaliplatin in colon cancer patients","volume":"18","author":"Burz","year":"2009","journal-title":"J. Gastrointestin Liver Dis."},{"key":"B4","first-page":"499","article-title":"Chlorogenic acid interaction with cisplatin and oxaliplatin: studies in cervical carcinoma cells","volume":"11","author":"Catanzaro","year":"2016","journal-title":"Nat. Prod. Commun."},{"key":"B5","unstructured":"Guidance for industry: estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers\n          \n          \n          2005"},{"key":"B6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","article-title":"Metastatic colorectal cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"34","author":"Cervantes","year":"2023","journal-title":"Ann. Oncol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1534735419828824","DOI":"10.1177\/1534735419828824","article-title":"Meta-analysis of 5-fluorouracil-based chemotherapy combined with traditional Chinese medicines for colorectal cancer treatment","volume":"18","author":"Chen","year":"2019","journal-title":"Integr. Cancer Ther."},{"key":"B8","first-page":"78","article-title":"Pharmacognosic identification of six medicinal plants of patrinia","volume":"39","author":"Chen","year":"2020","journal-title":"J. Anhui Univ. Chin. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/s00432-005-0072-6","article-title":"Clinical pharmacokinetics of oxaliplatin and 5-fluorouracil administered in combination with leucovorin in Korean patients with advanced colorectal cancer","volume":"132","author":"Cho","year":"2006","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00280-002-0550-3","article-title":"Population pharmacokinetics of oxaliplatin","volume":"51","author":"Delord","year":"2003","journal-title":"Cancer Chemother. Pharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00280-018-3722-5","article-title":"Population pharmacokinetics of FOLFIRINOX: a review of studies and parameters","volume":"83","author":"Deyme","year":"2019","journal-title":"Cancer Chemother. Pharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s00384-015-2191-0","article-title":"Lethal 5-fluorouracil toxicity in a colorectal patient with severe dihydropyrimidine dehydrogenase (DPD) deficiency","volume":"31","author":"Dhelens","year":"2016","journal-title":"Int. J. Colorectal Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1007\/pl00012514","article-title":"Cellular and molecular aspects of drugs of the future: oxaliplatin","volume":"59","author":"Di Francesco","year":"2002","journal-title":"Cell Mol. Life Sci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"11404","DOI":"10.1073\/pnas.1706617114","article-title":"Human SHMT inhibitors reveal defective glycine import as a targetable metabolic vulnerability of diffuse large B-cell lymphoma","volume":"114","author":"Ducker","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B15","doi-asserted-by":"publisher","first-page":"113264","DOI":"10.1016\/j.jep.2020.113264","article-title":"The herba patriniae (caprifoliaceae): a review on traditional uses, phytochemistry, pharmacology and quality control","volume":"265","author":"Gong","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.1365-2125.1989.tb05429.x","article-title":"Pharmacokinetics of (-)-folinic acid after oral and intravenous administration of the racemate","volume":"28","author":"Greiner","year":"1989","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3389\/fonc.2020.00586","article-title":"FOLFOX chemotherapy ameliorates CD8 T lymphocyte exhaustion and enhances checkpoint blockade efficacy in colorectal cancer","volume":"10","author":"Guan","year":"2020","journal-title":"Front. Oncol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ejpb.2023.04.001","article-title":"Cocrystallization of 5-fluorouracil with gallic acid: a novel 5-fluorouracil cocrystal displaying synergistic anti-tumor activity both in oral and intraperitoneal injection administration","volume":"187","author":"Hao","year":"2023","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"B19","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1142\/S0192415X17500379","article-title":"The genus patrinia: a review of traditional uses, phytochemical and pharmacological studies","volume":"45","author":"He","year":"2017","journal-title":"Am. J. Chin. Med."},{"key":"B20","first-page":"2203","article-title":"Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile","volume":"47","author":"Heggie","year":"1987","journal-title":"Cancer Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s11655-018-3002-6","article-title":"Patrinia scabiosaefolia inhibits growth of 5-FU-resistant colorectal carcinoma cells via induction of apoptosis and suppression of AKT pathway","volume":"25","author":"Huang","year":"2019","journal-title":"Chin. J. Integr. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"114532","DOI":"10.1016\/j.ejmech.2022.114532","article-title":"Discovery of dearomatized isoprenylated acylphloroglucinols with colon tumor suppressive activities in mice via inhibiting NFkappaB-FAT1-PDCD4 signaling activation","volume":"239","author":"Jiang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"B23","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/s0065-2571(00)00011-x","article-title":"Importance of dihydropyrimidine dehydrogenase (DPD) deficiency in patients exhibiting toxicity following treatment with 5-fluorouracil","volume":"41","author":"Johnson","year":"2001","journal-title":"Adv. Enzyme Regul."},{"key":"B24","doi-asserted-by":"publisher","first-page":"42176","DOI":"10.1038\/srep42176","article-title":"Bigelovin triggered apoptosis in colorectal cancer in vitro and in vivo via upregulating death receptor 5 and reactive oxidative species","volume":"7","author":"Li","year":"2017","journal-title":"Sci. Rep."},{"key":"B25","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.phymed.2018.03.065","article-title":"Turmeric extract, with absorbable curcumin, has potent anti-metastatic effect in vitro and in vivo","volume":"46","author":"Li","year":"2018","journal-title":"Phytomedicine"},{"key":"B26","doi-asserted-by":"publisher","first-page":"116264","DOI":"10.1016\/j.jep.2023.116264","article-title":"Patrinia villosa treat colorectal cancer by activating PI3K\/Akt signaling pathway","volume":"309","author":"Li","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.21873\/anticanres.17064","article-title":"Caffeic acid enhances anticancer drug-induced apoptosis in acid-adapted HCT116 colon cancer cells","volume":"44","author":"Lim","year":"2024","journal-title":"Anticancer Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"117982","DOI":"10.1016\/j.biopha.2025.117982","article-title":"Chlorogenic acid attenuates 5-fluorouracil-induced intestinal mucositis in mice through SIRT1 signaling-mediated oxidative stress and inflammatory pathways","volume":"186","author":"Lin","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/s0959-8049(01)00068-5","article-title":"High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX 7)","volume":"37","author":"Maindrault-Goebel","year":"2001","journal-title":"Eur. J. Cancer"},{"key":"B30","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1517\/14622416.3.4.485","article-title":"Implications of dihydropyrimidine dehydrogenase on 5-fluorouracil pharmacogenetics and pharmacogenomics","volume":"3","author":"Mattison","year":"2002","journal-title":"Pharmacogenomics"},{"key":"B31","doi-asserted-by":"publisher","first-page":"416","DOI":"10.4254\/wjh.v2.i11.416","article-title":"Hepatocellular carcinoma, with portal thrombus after viral eradication, disappeared by 5-fluorouracil and interferon","volume":"2","author":"Miura","year":"2010","journal-title":"World J. Hepatol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"578","DOI":"10.4274\/tjps.galenos.2019.69335","article-title":"Combined effects of protocatechuic acid and 5-fluorouracil on p53 gene expression and apoptosis in gastric adenocarcinoma cells","volume":"17","author":"Motamedi","year":"2020","journal-title":"Turk J. Pharm. Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.31557\/APJCP.2020.21.8.2337","article-title":"Outcome of FOLFOX and modified DCF chemotherapy regimen in patients with advanced gastric adenocarcinoma","volume":"21","author":"Pourghasemian","year":"2020","journal-title":"Asian Pac J. Cancer Prev."},{"key":"B34","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/hpb.12010","article-title":"An experimental study to identify the potential role of pharmacogenomics in determining the occurrence of oxaliplatin-induced liver injury","volume":"15","author":"Robinson","year":"2013","journal-title":"HPB Oxf."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s00280-019-03936-w","article-title":"Dihydropyrimidine dehydrogenase in the metabolism of the anticancer drugs","volume":"84","author":"Sharma","year":"2019","journal-title":"Cancer Chemother. Pharmacol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/j.bcp.2009.07.006","article-title":"Involvement of drug transporters in the synergistic action of FOLFOX combination chemotherapy","volume":"78","author":"Theile","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/BF03257473","article-title":"Evaluation of 5-fluorouracil pharmacokinetics in cancer patients with a c.1905+1G>A mutation in DPYD by means of a bayesian limited sampling strategy","volume":"51","author":"Van Kuilenburg","year":"2012","journal-title":"Clin. Pharmacokinet."},{"key":"B38","doi-asserted-by":"publisher","first-page":"117242","DOI":"10.1016\/j.lfs.2019.117242","article-title":"Correlation between mouse age and human age in anti-tumor research: significance and method establishment","volume":"242","author":"Wang","year":"2020","journal-title":"Life Sci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"114989","DOI":"10.1016\/j.jep.2022.114989","article-title":"Therapeutic effect of Patrinia villosa on TNBS-induced ulcerative colitis via metabolism, vitamin D receptor and NF-kappaB signaling pathways","volume":"288","author":"Wang","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"6566","DOI":"10.1038\/s41598-024-57115-w","article-title":"A systematic approach for authentication of medicinal patrinia species using an integration of morphological, chemical and molecular methods","volume":"14","author":"Wong","year":"2024","journal-title":"Sci. Rep."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1016\/j.bbrc.2018.08.005","article-title":"Effects of saponins of Patrinia villosa against invasion and metastasis in colorectal cancer cell through NF-kappaB signaling pathway and EMT","volume":"503","author":"Xia","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B42","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.lfs.2015.12.002","article-title":"Luteolin synergizes the antitumor effects of 5-fluorouracil against human hepatocellular carcinoma cells through apoptosis induction and metabolism","volume":"144","author":"Xu","year":"2016","journal-title":"Life Sci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1097\/CAD.0000000000000218","article-title":"Chlorogenic acid enhances the effects of 5-fluorouracil in human hepatocellular carcinoma cells through the inhibition of extracellular signal-regulated kinases","volume":"26","author":"Yan","year":"2015","journal-title":"Anticancer Drugs"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/0973-1296.175988","article-title":"A new biphenyl neolignan from leaves of Patrinia villosa (thunb.) juss","volume":"12","author":"Yan","year":"2016","journal-title":"Pharmacogn. Mag."},{"key":"B45","doi-asserted-by":"publisher","first-page":"6032","DOI":"10.3390\/molecules26196032","article-title":"Integrated network pharmacology analysis and in vitro validation revealed the potential active components and underlying mechanistic pathways of herba patriniae in colorectal cancer","volume":"26","author":"Yang","year":"2021","journal-title":"Molecules"},{"key":"B46","doi-asserted-by":"publisher","first-page":"154900","DOI":"10.1016\/j.phymed.2023.154900","article-title":"Mechanistic insights into the anti-tumor and anti-metastatic effects of Patrinia villosa water extract in colon cancer via modulation of TGF-beta R1-smad2\/3-E-cadherin and FAK-RhoA-cofilin pathways","volume":"117","author":"Yang","year":"2023","journal-title":"Phytomedicine"},{"key":"B47","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/ptr.2354","article-title":"Antitumor effects of saponin extract from Patrinia villosa (thunb.) juss on mice bearing U14 cervical cancer","volume":"22","author":"Zhang","year":"2008","journal-title":"Phytother. Res."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1756234\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T08:17:44Z","timestamp":1775031464000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1756234\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":47,"alternative-id":["10.3389\/fphar.2026.1756234"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1756234","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"article-number":"1756234"}}